SL
SCHEIBLER LUKAS Directeur de l'Innovation
Other M
US US · SEC (Form 4)
Discover the full record of transactions filed by SCHEIBLER LUKAS, Directeur de l'Innovation. Officer active across 1 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 17 filings have been logged. Total volume traded: €405k. The latest transaction was filed on 21 April 2022 (J). Regulator: SEC (Form 4). The full history is free.
Declarations 17 total
01,875 shares 0
Common Stock
SEC:0001127602-22-016013:0 · 21 Apr 2022
€7,734 609 shares @ €12.6989 0.0001% mcap 0.7% of flow
Common Stock
SEC:0001127602-22-011670:0 · 5 Apr 2022
€44,216 3,504 shares @ €12.6186 0.0008% mcap 4.1% of flow
Common Stock
SEC:0001127602-22-011526:0 · 4 Apr 2022
€143,799 11,496 shares @ €12.5086 0.0027% mcap 13.4% of flow
Common Stock
SEC:0001127602-22-011246:0 · 1 Apr 2022
€16,934 720 shares @ €23.5195 0.0003% mcap 1.6% of flow
Common Stock
SEC:0001127602-22-005041:0 · 14 Feb 2022
€68,301 1,666 shares @ €40.9968 0.0013% mcap 6.4% of flow
Common Stock
SEC:0001127602-22-004908:0 · 11 Feb 2022
€27,971 678 shares @ €41.2554 0.0005% mcap 2.6% of flow
Common Stock
SEC:0001127602-22-004774:0 · 10 Feb 2022
€121,035 10,000 shares @ €12.1035 0.0023% mcap 31.6% of flow
Common Stock
SEC:0001127602-22-004067 · 8 Feb 2022
€121,035 10,000 shares @ €12.1035 0.0023% mcap 11.3% of flow
Common Stock
SEC:0001127602-22-004067:0 · 8 Feb 2022
€22,225 642 shares @ €34.6191 0.0004% mcap 2.1% of flow
Common Stock
SEC:0001127602-22-002804:0 · 28 Jan 2022
€22,225 642 shares @ €34.6191 0.0004% mcap 5.8% of flow
Common Stock
SEC:0001127602-22-002804 · 28 Jan 2022
026,051 shares 0
Common Stock
SEC:0001127602-22-002071:0 · 21 Jan 2022
026,051 shares 0
Common Stock
SEC:0001127602-22-002071 · 21 Jan 2022
€71,374 3,021 shares @ €23.6261 0.0014% mcap 18.6% of flow
Common Stock
SEC:0001127602-22-001964 · 21 Jan 2022
€71,374 3,021 shares @ €23.6261 0.0014% mcap 6.6% of flow
Common Stock
SEC:0001127602-22-001964:0 · 21 Jan 2022
€168,428 3,417 shares @ €49.2912 0.0032% mcap 15.7% of flow
Common Stock
SEC:0001127602-21-019710:0 · 10 Jun 2021
€168,428 3,417 shares @ €49.2912 0.0032% mcap 44.0% of flow
Common Stock
SEC:0001127602-21-019710 · 10 Jun 2021
About SCHEIBLER LUKAS Lukas Scheibler is an executive at Apellis Pharmaceuticals, Inc.